Skip to content
Advertisement
Author profile
Sean Salai

Sean Salai

ssalai@washingtontimes.com

Sean Salai is the general assignment/culture reporter for The Washington Times. A former National desk intern and Metro clerk at The Washington Times, he also has served as a City Hall reporter at the Boca Raton News and as a special contributor at America Media. He can be reached at ssalai@washingtontimes.com.

Articles by Sean Salai

The injectable drug Ozempic, by Novo Nordisk, is shown on Saturday, July 1, 2023, in Houston. (AP Photo/David J. Phillip, File)

Study finds Mounjaro ‘significantly more’ effective than Ozempic for weight loss

Overweight and obese adults using popular diabetes medications to suppress their appetites are "significantly more likely" to shed pounds with Eli Lilly's Mounjaro than with Novo Nordisk's Ozempic, a new study has found, a result that could have major implications for one of the hottest new markets in the pharmaceutical field.

July 8, 2024